Is Camel Milk Good for Diabetes? What the Science Says

Camel milk shows genuine promise as a supplement for people with diabetes, but the evidence is still early-stage and comes mostly from small clinical trials and animal studies. The most consistent findings involve type 1 diabetes, where several trials report lower blood sugar, reduced insulin doses, and improved long-term glucose markers when camel milk is added to standard treatment. For type 2 diabetes, results are more mixed, and the studies are even smaller. The research is interesting enough that it keeps attracting attention from endocrinologists and food scientists, yet no major diabetes organization currently recommends camel milk as part of standard care.

The Strongest Evidence Comes From Type 1 Diabetes

The most striking results in the camel milk literature involve type 1 diabetes, a condition where the body’s own immune system destroys the insulin-producing cells of the pancreas. In a trial of young people with type 1 diabetes, adding about 500 milliliters of camel milk per day to their usual insulin treatment for 16 weeks led to dramatically better numbers compared with a group receiving standard care alone. Fasting blood sugar in the camel milk group averaged about 99 mg/dL versus 227 mg/dL in the control group, and HbA1c (a measure of average blood sugar over two to three months) dropped to roughly 7.2% compared with 9.6%. Daily insulin doses were cut roughly in half. Perhaps most intriguing, C-peptide levels, which indicate how much insulin the body is still making on its own, were about eight times higher in the camel milk group.¹

A separate two-year randomized controlled trial confirmed a similar pattern. People with type 1 diabetes who drank camel milk daily saw their HbA1c fall from about 7.8% to 5.4%, their average blood glucose drop substantially, and their daily insulin doses decrease from roughly 33 units to about 18 units. Three out of twelve participants in the camel milk group eventually stopped needing insulin entirely.² That last detail, people with type 1 diabetes going off insulin, is extraordinary if true. It would suggest that something in camel milk is either protecting remaining beta cells or stimulating their regeneration. But these are small trials with dozens of participants, not hundreds or thousands, so the findings need larger replication before anyone should make treatment decisions based on them.

Type 2 Diabetes Results Are More Ambiguous

When it comes to type 2 diabetes, the picture gets muddier. A systematic review that pooled available studies found a range of outcomes. One small trial of just twelve patients with type 2 diabetes showed significant drops in blood sugar, plasma insulin, triglycerides, and total cholesterol after camel milk consumption, along with a reduced need for medication.³ But another trial, specifically comparing camel milk to cow milk in people with type 2 diabetes, found that while insulin concentration rose by about 30% in the camel milk group, there were no significant differences in fasting blood sugar, lipid profiles, or blood pressure between the two groups.⁴

One randomized trial comparing camel milk head-to-head with cow milk in type 2 diabetes patients actually found that total cholesterol decreased more in the cow milk group, and insulin resistance showed no meaningful difference between the two.⁵ So the type 2 diabetes story is far from settled. Some trials show benefit, others show camel milk performing about the same as regular cow milk. The sample sizes across all of these studies are tiny, often in the single digits per group, which makes the results inherently unstable.

What Might Be Happening Biologically

Researchers have proposed several mechanisms to explain why camel milk might affect blood sugar. The most discussed involves insulin-like proteins. Camel milk contains proteins in its whey fraction that appear to activate the insulin receptor on human cells, triggering the same signaling pathways that insulin itself uses to move glucose out of the blood and into cells. Lab experiments have shown that camel milk whey proteins and peptides derived from them promote glucose uptake in liver cells and activate the downstream signaling pathways (including AKT and ERK1/2) that are central to insulin’s effects.⁶ Among the specific players is lactoferrin, a protein found at higher concentrations in camel milk than in cow milk.

Another avenue involves DPP-4 inhibition. DPP-4 is an enzyme that breaks down incretin hormones, which are gut hormones that stimulate insulin release after eating. Blocking DPP-4 is the mechanism behind a whole class of diabetes drugs (the “gliptins”). Peptides from camel milk have been shown to inhibit DPP-4 activity in lab settings, and in a mouse study, a camel milk-derived peptide called LLPK boosted levels of GLP-1 (one of the key incretin hormones) while reducing DPP-4 activity.⁷ This is suggestive, but there is a large gap between a peptide working in a test tube or a mouse model and that same peptide surviving digestion in a human stomach and reaching the bloodstream in meaningful concentrations.

A third proposed mechanism involves protection of the insulin-producing beta cells themselves. In animal models of diabetes, camel milk consumption has been associated with reduced oxidative stress and inflammation in the pancreas, and even regeneration of beta cells. One study in diabetic pigs found that camel milk improved beta-cell function and reduced both oxidative stress markers and inflammatory signals.⁸ Similarly, work in diabetic rats showed that camel milk restored normal insulin expression in pancreatic beta cells.⁹ These animal results help explain the clinical finding that C-peptide (a marker of the body’s own insulin production) rose dramatically in the type 1 diabetes trials. If something in camel milk really is preserving or reviving beta cells, that would be a fundamentally different kind of benefit from simply lowering blood sugar.

Effects on Cholesterol and Heart Risk

Diabetes is not just about blood sugar. People with diabetes face sharply elevated cardiovascular risk, and managing cholesterol and triglycerides is often as important as managing glucose. A meta-analysis that pooled randomized trials of camel milk in diabetic patients found significant reductions in total cholesterol, triglycerides, and LDL (“bad” cholesterol), along with a significant increase in HDL (“good” cholesterol), compared with usual care alone. The benefits were most consistent in patients with type 1 diabetes who consumed fresh camel milk over longer periods.¹⁰

This lipid benefit is worth noting because it suggests that even if camel milk’s blood sugar effects are modest or inconsistent in type 2 diabetes, the cardiovascular side of the equation might still be improved. That said, the heterogeneity across these trials was extremely high, meaning the individual study results varied widely from each other. The meta-analysis authors themselves flagged this as a limitation.

Kidney Protection in Diabetic Nephropathy

Kidney disease is one of the most serious long-term complications of diabetes. A few studies have looked at whether camel milk could slow or reverse diabetic kidney damage. In an animal model, camel milk reduced key markers of kidney damage, specifically blood urea and creatinine, as well as protein leakage in urine, while preserving the normal microscopic structure of the kidney’s filtering units.¹¹

In a human trial of patients with chronic kidney disease (not all of whom were diabetic), a combination of camel milk and a traditional supplement improved kidney filtration rate while lowering creatinine, blood urea nitrogen, triglycerides, and diastolic blood pressure.¹² Because that trial used a combination therapy, it is hard to attribute the improvements specifically to the camel milk. But the direction of the findings is consistent with the animal data.

Liver Fat and Metabolic Syndrome

Non-alcoholic fatty liver disease frequently accompanies type 2 diabetes, and the two conditions share underlying drivers like insulin resistance, chronic inflammation, and disrupted fat metabolism. Several animal studies have investigated camel milk’s effects on fatty liver, and the results are consistently positive. In rat models, eight weeks of camel milk reduced liver fat accumulation and inflammation, improved liver enzyme markers, and lowered insulin resistance.¹³ A separate study showed that camel milk activated specific fat-metabolism pathways in the liver, including upregulation of PPARs and the enzyme CPT1A, which are involved in breaking down fatty acids. The researchers concluded that camel milk could counteract the fat buildup, insulin resistance, and oxidative stress driven by a high-fat diet.¹⁴

In a study using diabetic rats, camel milk significantly reduced liver enzymes AST and ALT, along with blood sugar, HbA1c, triglycerides, and cholesterol, with effects described as comparable to the diabetes drug glibenclamide.¹⁵ No human trials have yet tested camel milk specifically for fatty liver disease, so this remains an area where the animal data is encouraging but unconfirmed in people.

The Gut Microbiome Connection

One of the newer angles in the research involves the gut. Peptides derived from camel milk have been shown to alter the composition of gut bacteria in diabetic mice, shifting the balance toward bacterial populations associated with better metabolic health. This included increases in short-chain fatty acid production, which is linked to improved insulin sensitivity and reduced inflammation.¹⁶ A 2025 mouse study echoed these findings, showing that camel milk peptides repaired gut microbiota disruptions, reduced intestinal permeability (sometimes called “leaky gut”), and boosted levels of proteins that hold gut-lining cells together.¹⁷

The microbiome angle is interesting because it provides a plausible pathway for camel milk’s effects that does not require its bioactive peptides to survive intact through digestion. Even if those peptides are partially broken down, they could still influence the bacterial communities in the gut, which in turn influence blood sugar regulation. It is an attractive theory, but this work is entirely in mice so far.

An Epidemiological Curiosity

One frequently cited piece of evidence comes from an observational study of the Raica community in northwest Rajasthan, India, a group known for regularly consuming camel milk. Among 501 Raica community members who drank camel milk, the prevalence of diabetes was 0%. Among a comparable non-Raica community that did not drink camel milk, prevalence was 5.5%. Even within the Raica community, those who did not consume camel milk had a slightly higher rate than those who did.¹⁸

This study is observational, so it cannot prove that camel milk is what protected the Raica from diabetes. The community differs from comparison groups in many ways besides milk preference: genetics, diet, physical activity patterns, and overall lifestyle. Still, it was one of the early findings that spurred interest in camel milk research and remains a compelling data point.

Safety Concerns With Raw Camel Milk

Many advocates of camel milk for diabetes insist that the milk must be consumed raw, arguing that pasteurization destroys the bioactive proteins responsible for its benefits. This is a serious safety concern. A study of raw camel milk samples in Ethiopia found that about 86% were contaminated with bacteria, including Staphylococcus, E. coli, and Salmonella. Nearly 40% of the total bacterial counts and 88% of coliform counts were at levels considered unsafe for human consumption.¹⁹

A 2024 analysis in Saudi Arabia confirmed that camel milk bought from street vendors carried considerably higher microbial loads than farm-sourced milk, with especially high levels of Staphylococcus aureus and E. coli.²⁰ For someone with diabetes who may already have a compromised immune system or kidney function, a foodborne infection from contaminated raw milk is not a theoretical risk. It is a real and potentially dangerous one. Pasteurized camel milk eliminates most of this concern, and some of the clinical trials that reported benefits used pasteurized milk. Whether pasteurization meaningfully reduces the bioactive properties remains an open question, but the infection risk of raw milk is well established.

Digestibility and Cow’s Milk Allergy

A practical advantage of camel milk is that many people who cannot tolerate cow’s milk handle camel milk well. Camel milk does not contain beta-lactoglobulin in the same form found in cow’s milk, and its casein structure differs. In a study of people who were lactose intolerant, all but two tolerated camel milk at doses up to 250 milliliters, and pasteurization did not affect that tolerance.²¹ Research has also shown that the majority of children with cow’s milk allergy tolerate camel milk without allergic reactions.²² This matters for people with diabetes who want to include dairy in their diet but react to cow’s milk. Camel milk gives them an option that appears to be well tolerated, independent of whether it provides any additional metabolic benefit.

Cost and Accessibility

Even if the health benefits of camel milk prove robust, the price tag is a major practical barrier. Camel milk retails at roughly $38 per liter in the United States, $19 per liter in Singapore, and around $7 per liter in India.²³ At a typical trial dose of 500 milliliters per day, you would be spending roughly $19 a day, or around $570 a month, in the U.S. That is more than most insulin regimens cost with insurance. In regions where camels are plentiful and camel milk is part of the local food system, cost is much less of an issue, but those regions tend to be where fresh raw milk is consumed, which brings the safety concerns described earlier.

Freeze-dried and powdered camel milk products have become available online and in specialty stores, broadening access somewhat. Whether these processed forms retain the same bioactive peptides and proteins that researchers believe drive the metabolic effects is unclear. Most of the clinical trials used fresh liquid camel milk, either raw or lightly pasteurized, so the relevance of powdered products to the trial findings is uncertain.

Where the Science Stands and What Is Missing

The pattern across the camel milk research is a lot of promising mechanisms, a handful of small human trials with impressive results, and no large-scale confirmatory evidence. The type 1 diabetes trials are the most compelling, but even the largest enrolled only a few dozen participants. Type 2 diabetes results are inconsistent. The animal and lab studies provide plausible biological mechanisms, but none have been validated in controlled human experiments designed to isolate which component of camel milk is responsible.

What the field needs are multicenter randomized trials with hundreds of participants, standardized milk preparation (raw versus pasteurized versus processed), and longer follow-up periods. It also needs head-to-head comparisons not just against usual care but against other milks, since any additional protein and fat source can affect blood sugar dynamics. Until those studies exist, camel milk is best understood as a food with intriguing but unproven metabolic properties, not a diabetes treatment. If you are considering trying it, the evidence does not suggest harm from pasteurized camel milk in moderate amounts, but it is no substitute for your prescribed medication, and the cost alone puts daily consumption out of reach for most people.